Phlox Therapeutics pioneers gene therapy to alleviate and cure different heart diseases.
Investors 3
| Date | Name | Website |
| - | Utrecht Ho... | utrechthol... |
| - | ROM Utrech... | romutrecht... |
| 13.06.2022 | UvA Ventur... | uvaventure... |
Mentions in press and media 2
| Date | Title | Description |
| 11.11.2024 | Phlox Therapeutics Secures New Funding to Advance RNA Therapies for Genetic Cardiomyopathies | Naarden, The Netherlands, 6 November 2024 – Phlox Therapeutics, a private biotechnology company focused on developing innovative RNA-based therapies for cardiomyopathies, has successfully raised new funding to accelerate its lead program on... |
| 19.05.2022 | AMC start-up Phlox Therapeutics is founded | Phlox Therapeutics is a recently founded biotech spin-off of the Academic Medical Center (AMC), originating from research from the lab of prof. dr. Yigal Pinto of the department of Experimental Cardiology. Supported by IXA and AMC Ventures ... |